Solara Active Pharma Sciences PP1

Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026

09 Apr, 2026 | 04:52pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the Exchange about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice

08 Apr, 2026 | 04:36pm • Source: BSE

Solara Active Pharma Sciences Limited has intimated the Exchange regarding the completion of dispatch of Second and Final Call Money Notice to the eligible partly...

07 Apr, 2026 | 07:41pm • Source: BSE

Intimation regarding closure of Trading Window for the quarter and year ended March 31, 2026

26 Mar, 2026 | 04:10pm • Source: BSE

Copy of the Newspaper Publication with respect to Record Date intimation for Second & Final Call on Rights Equity Shares

25 Mar, 2026 | 03:10pm • Source: BSE

Newspaper advertisement published regarding the special window for Re-lodgement of Transfer requests of physical shares by the shareholders.

25 Mar, 2026 | 02:51pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange that the Rights Issue Committee members at its meeting held on March 24, 2026, has approved...

24 Mar, 2026 | 10:44am • Source: BSE

Solara Active Pharma Sciences Limited has fixed April 02, 2026, as the record date for the purpose of making second and final call for the...

24 Mar, 2026 | 10:29am • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange about the receipt of Demand Notice from the Income Tax Authorities

18 Mar, 2026 | 07:00pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the Exchange the Voting Results alongwith the Scrutinizer''s Report with respect to the Postal Ballot.

10 Mar, 2026 | 12:54pm • Source: BSE

Solara Active Pharma Sciences Limited has submitted to the exchange a copy of the Scrutinizer''s Report and the Voting Results in respect of the Postal...

10 Mar, 2026 | 12:50pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange regarding the receipt of first call money pursuant to the second reminder Notice

04 Mar, 2026 | 06:39pm • Source: BSE

Intimation regarding the closure of wholly owned subsidiary of the Company in Brazil.

04 Mar, 2026 | 04:37pm • Source: BSE

Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.

10 Feb, 2026 | 05:48pm • Source: BSE

Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06, 2026.

06 Feb, 2026 | 06:47pm • Source: BSE

Monitoring Agency Report for the quarter ended December 31, 2025

06 Feb, 2026 | 06:33pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange about copy of Newspaper publication with respect to Second reminder for payment of the First Call...

06 Feb, 2026 | 03:56pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation in funds raised through Rights issue for the quarter...

06 Feb, 2026 | 02:36pm • Source: BSE

The Company has reviewed and adopted the revised " Policy for Determining Materiality of Events/Information for Disclosure to the Stock Exchanges" and "Policy for Governance...

06 Feb, 2026 | 02:24pm • Source: BSE

Solara Active Pharma Sciences Limited has informed the exchange regarding the Press release dated February 06, 2026 titled "Solara Announces Q3''26 Financial Results."

06 Feb, 2026 | 02:07pm • Source: BSE